9 December 2025
CABB Group Sells Jayhawk Fine Chemicals to Anupam Rasayan
CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand in the US and enhance its performance materials business. Transaction closes in January.